II. Pathophysiology
- Maternal Antibody Formation to fetal Rh- IgM (Agglutinates in Normal Saline) forms in 7 days- Does not cross placenta
 
- IgG (Agglutinates in Albumin) forms in 21 days- Crosses placenta easily
 
 
- IgM (Agglutinates in Normal Saline) forms in 7 days
- Results in Hemolytic Disease of the Newborn- Neonatal Hemolytic Anemia
- Fetal hydrops
 
III. Indications: RhoGAM (xD) Administration to Rh Negative Mother
- Standard Timing- Week 28 gestation
- Postpartum (under 3 days postpartum if baby Rh+)
 
- Additional Indications- Placenta Separation
- Labor Third Stage
- Termination or Spontaneous Abortion after 6 weeks- Rh Isoimmunization Risk 1.5 to 2%
- Risk increases to 4 to 5% with Dilation and Curettage
 
- Antepartum bleed
- Abruptio Placenta
- Abdominal Trauma
 
- Procedures (Give RhoGAM within 72 hours of procedure)- Amniocentesis or Cordocentesis
- Chorionic Villus Sampling
- External version
 
IV. Dosing
- Standard RhoGAM Dosing
- 
                          First Trimester Bleeding or Late Pregnancy Bleeding- RhoGAM dose based on Kleihauer-Betke Test
 
V. Labs: Rh Negative mother
- Consider checking Rh type of father if paternity sure
- Indirect Coombs Test for Rh Antibodies
- At Delivery: Test fetal blood- Maternal blood Sheep Rosette if fetus Rh Positive
- Sheep Rosette test results- Negative: Give 300 mcg RhoGAM
- Positive: Kleihauer Bettke based Rh vial numbers
 
 
VI. Imaging
- 
                          Fetal Ultrasound: signs of Fetal hydrops- Fetal Ascites
- Scalp edema
 
- 
                          Amniocentesis (replaced by MCA-PSV in most cases)- Obtain every 1-3 weeks when fetus > 26 weeks
- Follow Bilirubin level in amniotic fluid
- Liley Curve directs management per Gestational Age
 
- Middle Cerebral Artery Peak Systolic Velocity (MCA-PSV)- Best noninvasive marker for fetal Hemoglobin level
- Depends on accurate gestation age
- Reliable from 18-35 weeks
- Interpreted on curve to determine severity
 
- Genotyping- Determines if fetus at risk of Rh Sensitization
- Previously required Amniocentesis
- Now cell free fetal DNA detected in maternal serum
 
VII. Management (Based on severity evaluation above)
- Neonatology Consultation
- Corticosteroids may be indicated
- Phenobarbital may be indicated
- Consider reducing maternal antibodies <18 weeks- Plasmapheresis of maternal serum or
- Intravenous IgG
 
- Consider early delivery (32-35 weeks)- Do not wait for Fetal hydrops
 
- Intrauterine transfusion via Ultrasound guidance- Indicated for severe cases based on testing above- Intravascular fetal transfusion via Umbilicus
- Intraperitoneal transfusion- Poorly absorbed in Fetal hydrops
 
 
 
- Indicated for severe cases based on testing above
